The results of this “Molnupiravir is also being studied in a Phase III trial for preventing infection in people exposed to the coronavirus.” will even be more interesting.

[SecGen]

The results of this “Molnupiravir is also being studied in a Phase III trial for preventing infection in people exposed to the coronavirus.” will even be more interesting.
Positive outcomes will dramatically reduce the need for COVID vaccines.

Merck pill seen as 'huge advance,' raises hope of preventing COVID-19 deaths